| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0002 | 1 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 4.5e-07 | 1 |